I don't dispute that the science is advanced over traditional type or other novel approaches, but in terms of it coming to market, it is like Cortex...probably 12 years ago. UPenn is Ivy League, so I don't doubt the potential. But as an investment, watch out, especially if you are/were in Corx. It looks more like Corx: Part Deux.
I'll bet you $50 they put out a PR next week for something. lol
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.